MGMT and glioblastoma: The CeTeg/NOA‐09 trial was a very recently published phase III study of 141 newly diagnosed patients with MGMT‐methylated glioblastoma randomized to receive standard therapy with concurrent and adjuvant TMZ vs experimental therapy with CCNU/TMZ.